{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:35:38Z","timestamp":1779341738418,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,15]]},"DOI":"10.7759\/cureus.71535","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T13:59:21Z","timestamp":1729000761000},"source":"Crossref","is-referenced-by-count":1,"title":["Everolimus-Associated Thrombotic Microangiopathy Following Renal Transplant: A Case Report"],"prefix":"10.7759","author":[{"given":"Zachary Chi Wai","family":"Leong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason Henn Leong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"See Yee","family":"Khor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yew Fong","family":"Liew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.642864","article-title":"Thrombotic microangiopathy after kidney transplantation: an underdiagnosed and potentially reversible entity","volume":"8","author":"\u00c1vila A","year":"2021","unstructured":"\u00c1vila A, Gavela E, Sancho A. Thrombotic microangiopathy after kidney transplantation: an underdiagnosed and potentially reversible entity. Front Med (Lausanne). 2021, 8:642864. 10.3389\/fmed.2021.642864","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri ZL","year":"2015","unstructured":"Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015, 125:616-8. 10.1182\/blood-2014-11-611335","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajkd.2003.07.008","article-title":"Thrombotic microangiopathy after renal transplantation in the United States","volume":"42","author":"Reynolds JC","year":"2003","unstructured":"Reynolds JC, Agodoa LY, Yuan CM, Abbott KC. Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis. 2003, 42:1058-68. 10.1016\/j.ajkd.2003.07.008","journal-title":"Am J Kidney Dis"},{"key":"ref4","article-title":"Causes of acute thrombotic microangiopathy in patients receiving kidney transplantation","volume":"2","author":"Jumani A","year":"2004","unstructured":"Jumani A, Hala K, Tahir S, et al.. Causes of acute thrombotic microangiopathy in patients receiving kidney transplantation. Exp Clin Transplant. 2004, 2:268-72.","journal-title":"Exp Clin Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00492.x","article-title":"Cyclosporine-associated thrombotic microangiopathy in renal allografts","volume":"55","author":"Zarifian A","year":"1999","unstructured":"Zarifian A, Meleg-Smith S, O'donovan R, Tesi RJ, Batuman V. Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int. 1999, 55:2457-66. 10.1046\/j.1523-1755.1999.00492.x","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14118","article-title":"Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors","volume":"26","author":"Tasaki M","year":"2019","unstructured":"Tasaki M, Saito K, Nakagawa Y, et al.. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors. Int J Urol. 2019, 26:1128-37. 10.1111\/iju.14118","journal-title":"Int J Urol"},{"key":"ref7","article-title":"A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss","volume":"13","author":"Katafuchi R","year":"1999","unstructured":"Katafuchi R, Saito S, Ikeda K, Hirano T, Yanase T, Nakashima K, Fujimi S. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss. Clin Transplant. 1999, 13:54-8.","journal-title":"Clin Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients","volume":"325","author":"Bell WR","year":"1991","unstructured":"Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med. 1991, 325:398-403. 10.1056\/NEJM199108083250605","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock GA","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991, 325:393-7. 10.1056\/NEJM199108083250604","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.10.011","article-title":"Update on the native kidney biopsy: core curriculum 2019","volume":"73","author":"Luciano RL","year":"2019","unstructured":"Luciano RL, Moeckel GW. Update on the native kidney biopsy: core curriculum 2019. Am J Kidney Dis. 2019, 73:404-15. 10.1053\/j.ajkd.2018.10.011","journal-title":"Am J Kidney Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001239","article-title":"Rejection-associated phenotype of de novo thrombotic microangiopathy represents a risk for premature graft loss","volume":"7","author":"Petr V","year":"2021","unstructured":"Petr V, Hruba P, Kollar M, et al.. Rejection-associated phenotype of de novo thrombotic microangiopathy represents a risk for premature graft loss. Transplant Direct. 2021, 7:e779. 10.1097\/TXD.0000000000001239","journal-title":"Transplant Direct"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens M","year":"2009","unstructured":"Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009, 4:481-508. 10.2215\/CJN.04800908","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref13","article-title":"The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients","volume":"76","author":"Sahin G","year":"2011","unstructured":"Sahin G, Akay OM, Bal C, Yalcin AU, Gulbas Z. The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients. Clin Nephrol. 2011, 76:218-25.","journal-title":"Clin Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00428.x","article-title":"Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination","volume":"4","author":"Fortin MC","year":"2004","unstructured":"Fortin MC, Raymond MA, Madore F, Fug\u00e8re JA, P\u00e2quet M, St-Louis G, H\u00e9bert MJ. Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination. Am J Transplant. 2004, 4:946-52. 10.1111\/j.1600-6143.2004.00428.x","journal-title":"Am J Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v8.i5.122","article-title":"Thrombotic microangiopathy after renal transplantation: current insights in de novo and recurrent disease","volume":"8","author":"Abbas F","year":"2018","unstructured":"Abbas F, El Kossi M, Kim JJ, Sharma A, Halawa A. Thrombotic microangiopathy after renal transplantation: current insights in de novo and recurrent disease. World J Transplant. 2018, 8:122-41. 10.5500\/wjt.v8.i5.122","journal-title":"World J Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2014.07.062","article-title":"Everolimus, cyclosporine, and thrombotic microangiopathy: clinical role and preventive tools in renal transplantation","volume":"46","author":"Nava F","year":"2014","unstructured":"Nava F, Cappelli G, Mori G, et al.. Everolimus, cyclosporine, and thrombotic microangiopathy: clinical role and preventive tools in renal transplantation. Transplant Proc. 2014, 46:2263-8. 10.1016\/j.transproceed.2014.07.062","journal-title":"Transplant Proc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.90276.2008","article-title":"Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury","volume":"295","author":"Kwon O","year":"2008","unstructured":"Kwon O, Hong SM, Sutton TA, Temm CJ. Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury. Am J Physiol Renal Physiol. 2008, 295:F351-9. 10.1152\/ajprenal.90276.2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03178.x","article-title":"De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection","volume":"10","author":"Satoskar AA","year":"2010","unstructured":"Satoskar AA, Pelletier R, Adams P, et al.. De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection. Am J Transplant. 2010, 10:1804-11. 10.1111\/j.1600-6143.2010.03178.x","journal-title":"Am J Transplant"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2003.00222.x","article-title":"Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation","volume":"3","author":"Karthikeyan V","year":"2003","unstructured":"Karthikeyan V, Parasuraman R, Shah V, Vera E, Venkat KK. Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation. Am J Transplant. 2003, 3:1289-94. 10.1046\/j.1600-6143.2003.00222.x","journal-title":"Am J Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/297004-everolimus-associated-thrombotic-microangiopathy-following-renal-transplant-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T13:59:24Z","timestamp":1729000764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/297004-everolimus-associated-thrombotic-microangiopathy-following-renal-transplant-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.71535","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,15]]}}}